Instructions for Rabevita (Rabeprazole) 20 mg
Rabevita (Rabeprazole) 20 mg
Description:
Tablets coated with an intestinal-soluble shell 20 mg: round double-convex tablets coated with a yellow intestinal-soluble shell. Cross-section view: white core.
Active substances
Rabeprazole
Release form
Tablets
Composition
Each 20 mg EC-soluble pill contains:
The composition of the core of the tablet: Active substance: sodium rabeprazole 20 mg. Auxiliary substances: mannitol - 40.0 mg, magnesium oxide - 62.0 mg, hyprolose - 19.5 mg, hyprolose - 3.0 mg, magnesium stearate - 1.5 mg.
The composition of the inner shell of the tablet: ethyl cellulose - 1.0 mg, magnesium oxide - 1.0 mg. The composition of the intestinal-soluble shell pill: hypromellose phthalate - 13,6 mg, dibutylsebacate - 1,4 mg, iron oxide yellow - 0,1 mg, titanium dioxide - 0,7 mg, talc - 1,3 mg.
Pharmacological effect Rabevita:
Sodium rabeprazole is a class of antisecretory substances derived from benzimidazole. Sodium rabeprazole suppresses gastric juice secretion by specific H+/C+ ATPase inhibition on the secretory surface of parietal cells in the stomach. N+/C+ ATPase is a protein complex that functions as a proton pump, thus sodium rabeprazole is an inhibitor of the proton pump in the same 11uke and blocks the final stage of acid production.
Testimony Rabevita:
- Gastric ulcers in exacerbation and anastomosis ulcers Duodenal ulcer in exacerbation Erosive and ulcerative
- gastroesophageal reflux disease or reflux esophagitis Supportive therapy of gastroesophageal reflux disease Non-erosive
- gastroesophageal reflux disease 3ollinger-Ellison syndrome and other conditions characterized by pathological
- hypersecretion In combination with appropriate antibacterial therapy for the eradication of Helicobacter pyloriy ulcers.
Method of use and doses Rabevita:
Inwards, in a dose of twenty mg once a day. Tablets should not be chewed or chopped. The tablets should be swallowed whole. It is recommended to take the drug in the morning, before eating. It has been found that neither time of day nor food consumption influences the activity of sodium rabeprazole, but the recommended time of taking tablets contributes to better adherence of patients to the treatment regimen.
Storage Conditions
At temperatures not exceeding 25 °C. Best before date: three years.
